Bentley Systems, Incorporated (BSY) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on August 6, might help the stock move higher if these key numbers are better ...

Core Insights - Coeur Mining (CDE) is expected to report a year-over-year increase in earnings driven by higher revenues, with a consensus estimate of $0.18 per share, reflecting a significant increase of +1900% [3] - Revenues are projected to reach $474.4 million, marking an increase of 113.7% compared to the same quarter last year [3] - The earnings report is anticipated to be released on August 6, and the actual results will significantly influence the stock price movement [2] Estimate Revisions - The consensus EPS estimate has been revised 45.24% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for Coeur Mining aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] Earnings History - In the last reported quarter, Coeur Mining exceeded the expected earnings of $0.02 per share by delivering $0.11, resulting in a surprise of +450.00% [13] - Over the past four quarters, the company has beaten consensus EPS estimates three times [14] Industry Comparison - Centrus Energy Corp. (LEU), another player in the mining sector, is expected to report an EPS of $0.71, which represents a year-over-year decline of -62.4% [18] - Centrus Energy's revenues are projected to be $136.84 million, down 27.6% from the previous year, with a consensus EPS estimate revised 106% higher recently [19]

Light & Wonder (LNW) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 6. ...

Core Viewpoint - The market anticipates a year-over-year decline in Parsons' earnings due to lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Parsons is expected to report quarterly earnings of $0.74 per share, reflecting an 11.9% decrease year-over-year, with revenues projected at $1.61 billion, down 3.9% from the previous year [3]. - The consensus EPS estimate has been revised down by 6.62% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +2.49% for Parsons, suggesting analysts have recently become more optimistic about the company's earnings prospects [12]. - However, Parsons currently holds a Zacks Rank of 5, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Parsons exceeded the expected earnings of $0.74 per share by delivering $0.78, resulting in a surprise of +5.41% [13]. - Over the past four quarters, Parsons has beaten consensus EPS estimates three times [14]. Market Reaction Considerations - An earnings beat or miss alone may not dictate stock price movement, as other factors can influence investor sentiment [15]. - While betting on stocks expected to beat earnings can increase success odds, it is essential to consider other influencing factors [16][17].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Pinnacle West due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2] Earnings Expectations - Pinnacle West is expected to report quarterly earnings of $1.58 per share, reflecting a year-over-year decrease of 10.2% [3] - Revenues are projected to be $1.26 billion, down 3.4% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 3.32% higher in the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Pinnacle West matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10] - Pinnacle West currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat [12] Historical Performance - In the last reported quarter, Pinnacle West was expected to post earnings of $0.05 per share but instead reported a loss of -$0.04, resulting in a surprise of -180.00% [13] - Over the past four quarters, the company has beaten consensus EPS estimates three times [14] Industry Comparison - Duke Energy, another player in the electric power industry, is expected to report earnings of $1.25 per share, indicating a year-over-year increase of 5.9% [18] - Duke Energy's revenues are expected to be $7.4 billion, up 3.2% from the previous year, but it has an Earnings ESP of -3.66% and a Zacks Rank of 4 [19][20]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Rockwell Automation despite higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Rockwell Automation is expected to report quarterly earnings of $2.69 per share, reflecting a -0.7% change year-over-year, while revenues are projected at $2.07 billion, an increase of 0.9% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.86% higher in the last 30 days, indicating a positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +1.66% for Rockwell Automation, suggesting a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Rockwell Automation exceeded the expected earnings of $2.09 per share by delivering $2.45, resulting in a surprise of +17.22% [13]. The company has beaten consensus EPS estimates in all of the last four quarters [14]. Additional Considerations - While an earnings beat can influence stock movement, other factors may also play a significant role in determining stock performance post-earnings release [15].

Core Viewpoint - The market anticipates a year-over-year decline in Sunrun's earnings despite an increase in revenues, with the actual results being crucial for stock price movement [1][2]. Company Summary - Sunrun is expected to report a quarterly loss of $0.18 per share, reflecting a year-over-year change of -132.7% [3]. - Revenue for the upcoming quarter is projected to be $557.23 million, which is a 6.4% increase from the same quarter last year [3]. - The consensus EPS estimate has been revised down by 104.15% over the last 30 days, indicating a significant reassessment by analysts [4]. Earnings Prediction Insights - The Zacks Earnings ESP for Sunrun is -47.26%, suggesting a bearish outlook from analysts regarding the company's earnings prospects [12]. - The stock currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [12]. - Historically, Sunrun has beaten consensus EPS estimates three out of the last four quarters, with a notable surprise of +190.91% in the last reported quarter [13][14]. Industry Context - In the broader solar industry, Shoals Technologies Group is expected to report earnings of $0.08 per share, indicating a year-over-year decline of -20% [18]. - Shoals Technologies' revenue is anticipated to be $104.44 million, up 5.2% from the previous year [18]. - The consensus EPS estimate for Shoals has been revised up by 1.7% over the last 30 days, but it still has an Earnings ESP of -10.91%, complicating predictions for an earnings beat [19].

Group 1 - Steris is expected to report a year-over-year increase in earnings, with a consensus estimate of $2.32 per share, reflecting a +14.3% change, and revenues projected at $1.36 billion, up 6.2% from the previous year [3][12] - The earnings report is anticipated to be released on August 6, and the actual results will significantly influence the stock price, depending on whether they meet or exceed expectations [2][12] - The consensus EPS estimate has been revised 0.1% higher in the last 30 days, indicating a slight positive adjustment by analysts [4] Group 2 - The Earnings ESP for Steris is -3.24%, suggesting a bearish outlook from analysts, which complicates the prediction of an earnings beat [12] - Historically, Steris has beaten consensus EPS estimates three out of the last four quarters, with a recent surprise of +5.79% in the last reported quarter [13][14] - The Zacks Rank for Steris is currently 3 (Hold), which, combined with the negative Earnings ESP, makes it challenging to predict a positive earnings surprise [12][19] Group 3 - In the broader industry context, CVRx is expected to report a loss of $0.52 per share, indicating a +20% year-over-year change, with revenues projected at $13.46 million, up 14% [18] - CVRx's consensus EPS estimate has remained unchanged over the last 30 days, but it has an Earnings ESP of -0.65%, reflecting a lower Most Accurate Estimate [19]

Company Overview - RB Global (RBA) is expected to report a year-over-year increase in earnings, with a projected EPS of $0.95, reflecting a +1.1% change, and revenues of $1.12 billion, up 2.3% from the previous year [3][12]. Earnings Expectations - The consensus outlook indicates that the stock price may rise if the actual earnings exceed expectations in the upcoming report, scheduled for August 6 [2][12]. - The company has an Earnings ESP of +2.80%, suggesting analysts have recently become more optimistic about its earnings prospects [12]. Historical Performance - In the last reported quarter, RB Global exceeded the expected EPS of $0.86 by delivering $0.89, resulting in a surprise of +3.49% [13]. - Over the past four quarters, the company has consistently beaten consensus EPS estimates [14]. Analyst Sentiment - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - Despite the positive Earnings ESP, the company currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12][17]. Industry Comparison - Fidelity National Information Services (FIS), a peer in the Financial Transaction Services industry, is expected to report an EPS of $1.36, with revenues projected at $2.58 billion, reflecting a 3.5% increase from the previous year [18][19]. - FIS has an Earnings ESP of +0.67% and a Zacks Rank of 2, indicating a higher likelihood of beating consensus EPS estimates [20].

Company Overview - Vir Biotechnology, Inc. (VIR) is expected to report a year-over-year increase in earnings driven by higher revenues for the quarter ended June 2025, with a consensus outlook indicating a quarterly loss of $0.72 per share, reflecting a +29.4% change from the previous year [1][3] - Revenues are anticipated to reach $7.64 million, representing a significant increase of 148.1% compared to the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised 7.54% higher in the last 30 days, indicating a collective reassessment by analysts [4] - The Most Accurate Estimate for Vir Biotechnology is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -22.91%, suggesting a bearish outlook from analysts [12] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, but the predictive power is significant primarily for positive readings [9][10] - Vir Biotechnology currently holds a Zacks Rank of 3, which complicates the prediction of an earnings beat given the negative Earnings ESP [12] Historical Performance - In the last reported quarter, Vir Biotechnology was expected to post a loss of $0.83 per share but actually reported a loss of -$0.88, resulting in a surprise of -6.02% [13] - Over the past four quarters, the company has only beaten consensus EPS estimates once [14] Industry Context - In the Zacks Medical - Biomedical and Genetics industry, Beam Therapeutics Inc. (BEAM) is also expected to report a loss of $1.04 per share for the same quarter, with revenues projected at $13.79 million, up 17.2% year-over-year [18][19] - Beam Therapeutics has an Earnings ESP of -23.08% and a Zacks Rank of 4, indicating challenges in predicting an earnings beat [20]